Dec 17, 2019
Ethical CBD Marketing: How to avoid FDA, FTC, and class action trouble
Asa's Regulatory Education Series
The first Boulder Hemp-CBD Group Meet-Up hosted by Asa (In-person)
What can we learn from recent "Big 15" Warning Letters, revised Consumer Update, and recent class action news?
Have you ever wondered why some companies receive FDA Warning Letters and are unsure about how to ethically market your product without getting into trouble?
Are you looking for clarification about what the FDA is enforcing and how to read Warning Letter trends?
What is a claim and what are the risks when making them on your website or social media? Can I get in trouble for "Liking" a post?
If I link to a clinical study is this allowable? Do I need to be careful with blogs?
What is the Farm Bill IFR and how do I submit comments?
What is an attorney's opinion on recent class-action lawsuits?
This event will focus on a discussion about the dos and don'ts of labeling, marketing, and selling Hemp-CBD and much more! I am honored to be joined by very special guests:
Patrick McCarthy, Validcare CEO
Frank Robison, Founder of the Robison Law Group LLC.